Highlighting this for #WorldObesityDay2024 "More than 90% of people with #obesity get no medical care for obesity whatsoever. None." How do we achieve true #healthcare? 👉Stop #weightstigma and #weightbias 👉⬆️access to evidence-based therapies 👉(Ironically), treat obesity

The #FLOW trial top-line results just dropped showing a 24% reduction in a kidney and cardiovascular composite outcome in #semaglutide treated patients. FLOW enrolled 3534 patients with #type2diabetes and #CKD Composite primary outcome = ⬇️50% in GFR, ESKD, CV/renal death

Thank you for having me on! Especially during obesity care week. OAC Obesity Care Week Obesity Medicine Association

Employer coverage of comprehensive #obesity care is critical to uplift women and promote workforce health. We appreciate National Alliance’s thoughtful, holistic coverage recommendations for comprehensive obesity care. Learn more: nationalalliancehealth.org/resources/addr…

Even with a 60% discount/rebate, the cost to treat 63 qualifying people with sema 2.4 mg over 3 years to prevent one MACE is $1.1 million. 🤯 cardiovascularbusiness.com/topics/healthc…

Show me a practical, feasible plan for fixing the US food environment so thoroughly that the new obesity drugs are no longer needed. Until then, let's stop presenting diet and drugs as competing approaches.

Says Sarah Ro, MD, #GLP1orBust is a lame way to think about #ObesityCare. Daniel Engber reminds us that people can get half the effect of #Ozempic for 1/30th of the expense. Nope, obesity medicine wasn't born yesterday. 1/2 conscienhealth.org/2024/03/obesit…

In this era of drug shortages, may I remind you... It's possible to achieve 10% #weightloss with metformin bupropion topiramate phentermine HT Michael Weintraub, MD pubmed.ncbi.nlm.nih.gov/36810608/ #access #BeforeGLP1s

There is no rational reason, other than greed, for Novo Nordisk to charge Americans nearly $1,000 a month for Ozempic when it costs less than $5 to manufacture it and can be purchased in Germany for just $59. Novo must substantially reduce the price of Ozempic in the US now.

People need to stop crapping on primary care doctors. They do not have the time or resources to do their job to the fullest of their abilities & that’s not their fault. They should be compensated more. They experience increased rates of burn out compared to other specialties.

Members of Obesity Care Advocacy Network are up on Capitol Hill today to meet with Members of Congress about the Treat and Reduce Obesity Act. Doctors know why it's imp to increase access to all #obesity treatments through #TROA. Now we need Congress to Act.

MHS AOM utilization rates <1% despite coverage since 2018. 0.44% of eligible ADSMs received AOMs. P&T already improved AOM coverage. Time for DoD to act. Treat obesity like a disease. Revise policies to allow AOM use in AD! @SecDef Mark Hertling doi.org/10.1002/oby.24…

Join us tomorrow at 2pm via Zoom for ASP's "Experts Weigh In: Fighting Obesity in the Military 2024" americansecurityproject.org/event/experts-…

Sage advice from @jessica_bunin. Check it out. Josh Hartzell, MD, MS-HPEd Benjamin Vipler, MD, MEd Richele Corrado

This message definitely hit home for me today! Recognizing feedback as someone looking out for me and trying to make me better - 💯

Last month, HealthyWomen.org hosted a great webinar featuring several experts who spoke about a variety of available treatment options for women living with obesity. If you missed it, you can still watch it here: healthywomen.org/video/webinar-…

We’re off to a great start at the National Obesity Policy Forum with the first panel featuring Dr. Alyson Goodman, CDC, and Dr. Andrew Bremer, NIH! They shared current research and innovation to address #obesity in the U.S. Obesity Care Advocacy Network American Diabetes Association

Critical conversation about the opportunities to improve treatment and care for active duty military personnel & veterans, as well as recruitment: 77% of young men and women are ineligible to serve, with obesity being one of the most common reasons for disqualification.